Statera BioPharma Inc (STAB)
0.0007
0.00 (0.00%)
USD |
OTCM |
May 03, 16:00
Statera BioPharma Max Drawdown (5Y): 100.00% for April 30, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| April 30, 2024 | 100.00% |
| March 31, 2024 | 100.00% |
| February 29, 2024 | 100.00% |
| January 31, 2024 | 100.00% |
| December 31, 2023 | 100.00% |
| November 30, 2023 | 100.00% |
| October 31, 2023 | 100.00% |
| September 30, 2023 | 100.00% |
| August 31, 2023 | 100.00% |
| July 31, 2023 | 99.98% |
| June 30, 2023 | 99.85% |
| May 31, 2023 | 99.85% |
| April 30, 2023 | 99.85% |
| March 31, 2023 | 99.85% |
| February 28, 2023 | 99.74% |
| January 31, 2023 | 99.73% |
| December 31, 2022 | 99.15% |
| November 30, 2022 | 98.98% |
| October 31, 2022 | 98.68% |
| September 30, 2022 | 98.66% |
| August 31, 2022 | 98.11% |
| July 31, 2022 | 97.84% |
| June 30, 2022 | 97.81% |
| May 31, 2022 | 97.81% |
| April 30, 2022 | 97.81% |
| Date | Value |
|---|---|
| March 31, 2022 | 96.71% |
| February 28, 2022 | 95.65% |
| January 31, 2022 | 97.42% |
| December 31, 2021 | 97.49% |
| November 30, 2021 | 97.49% |
| October 31, 2021 | 97.91% |
| September 30, 2021 | 98.03% |
| August 31, 2021 | 98.12% |
| July 31, 2021 | 98.12% |
| June 30, 2021 | 98.12% |
| May 31, 2021 | 98.12% |
| April 30, 2021 | 98.12% |
| March 31, 2021 | 98.12% |
| February 28, 2021 | 98.12% |
| January 31, 2021 | 98.12% |
| December 31, 2020 | 98.12% |
| November 30, 2020 | 98.12% |
| October 31, 2020 | 98.12% |
| September 30, 2020 | 98.12% |
| August 31, 2020 | 98.12% |
| July 31, 2020 | 98.12% |
| June 30, 2020 | 98.12% |
| May 31, 2020 | 98.12% |
| April 30, 2020 | 98.12% |
| March 31, 2020 | 98.50% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
95.65%
Minimum
Feb 2022
100.00%
Maximum
Nov 2023
98.66%
Average
98.58%
Median
Max Drawdown (5Y) Benchmarks
| Humanigen Inc | 100.0% |
| Cantabio Pharmaceuticals Inc | 99.94% |
| Affymax Inc | 99.91% |
| RVL Pharmaceuticals PLC | 100.00% |
| Scopus BioPharma Inc | -- |